secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2023-08-31T23:59:59+00:00
Accession:  0001493152-23-031061
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes spinout of BriaPro to shareholders; retains 66.6% stake
-----------------------------------------------------------------------

- Closed plan of arrangement spinning out Bria-TILsRx™ and PKCδ inhibitors to BriaPro.
- Shareholders receive one BriaPro share and one new BriaCell share per existing share.
- BriaCell now owns ~66.6% (31,963,452 shares) of BriaPro's outstanding shares.
- BriaPro becomes unlisted reporting issuer in Canada; BriaCell remains on Nasdaq and TSX.
- New BriaCell common shares expected to trade on or about Sept 5, 2023 under 'BCT'.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223031061/0001493152-23-031061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223031061/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer